Open access
Jul 2026
AAV-mediated gene therapy demonstrates phenotypic rescue in a mouse model of Cockayne syndrome
Treatment with AAV9-CSA resulted in a significant increase in life span, and broad distribution of human CSA in the brain and heart, without evidence of vector-related toxicity, and paves the way for clinical translation of an AAV gene therapy for patients with CS into humans.
A. R. Batista, Aine C. Scholand, William S. Callahan et al.
· Journal of Clinical Investig... · 0 citations